Lysis of MM cells treated with CD38 mAb is dose‐dependent and can occur in the presence of bone marrow‐derived mesenchymal stem/stromal cells, and in patient‐derived peripheral blood mononuclear cells (PBMCs).81 The gene discussed is CD38; the disease is Miyoshi myopathy.